These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 996054)

  • 1. Acute and chronic single dose effects of LSD-25 on visual discrimination in rats.
    Friedman H; Carey RJ
    Pharmacol Biochem Behav; 1976 Aug; 5(2):223-6. PubMed ID: 996054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects of LSD-25 on easy and hard visual discrimination in rats.
    Friedman H; Carey RJ
    Pharmacol Biochem Behav; 1978 Dec; 9(6):809-12. PubMed ID: 746054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of LSD-25 on performance of a visual discrimination task in brain-damaged rats.
    Friedman H; Carey RJ
    Pharmacol Biochem Behav; 1975; 3(3):421-4. PubMed ID: 1153444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of repeated administration of the monoamine oxidase inhibitor phenelzine on the discriminability of d-lysergic acid diethylamide (LSD) and 1-(m-trifluoromethylphenyl) piperazine (TFMPP).
    Cunningham KA; Carroll BA; Appel JB
    Psychopharmacology (Berl); 1986; 89(1):134-5. PubMed ID: 3090587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation between the stimulus effects of l-5-hydroxytryptophan and LSD.
    Cunningham KA; Callahan PM; Appel JB
    Eur J Pharmacol; 1985 Jan; 108(2):179-86. PubMed ID: 3156756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing the selectivity of drug discrimination procedures.
    Appel JB; West WB; Rolandi WG; Alici T; Pechersky K
    Pharmacol Biochem Behav; 1999 Oct; 64(2):353-8. PubMed ID: 10515312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice.
    Benneyworth MA; Smith RL; Barrett RJ; Sanders-Bush E
    Psychopharmacology (Berl); 2005 Jun; 179(4):854-62. PubMed ID: 15645221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex.
    Gresch PJ; Smith RL; Barrett RJ; Sanders-Bush E
    Neuropsychopharmacology; 2005 Sep; 30(9):1693-702. PubMed ID: 15756304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A drug discrimination analysis of lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, a LSD-antagonist.
    Colpaert FC; Niemegeers CJ; Janssen PA
    J Pharmacol Exp Ther; 1982 Apr; 221(1):206-14. PubMed ID: 7062283
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative discriminative stimulus effects of 5-methoxy-N,N-dimethyltryptamine and LSD.
    Young R; Rosecrans JA; Glennon RA
    Life Sci; 1982 Jun; 30(24):2057-62. PubMed ID: 7109835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An analysis of some perceptual effects of morphine, chlorpromazine, and LSD.
    Hernandez LL; Appel JB
    Psychopharmacology (Berl); 1979 Jan; 60(2):125-30. PubMed ID: 106422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs and visual perception: effects of LSD, morphine and chloropromazine on accuracy, bias and speed.
    West KB; Hernandez LL; Appel JB
    Psychopharmacology (Berl); 1982; 76(4):320-4. PubMed ID: 6812104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonergic/glutamatergic interactions: the effects of mGlu2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli.
    Winter JC; Eckler JR; Rabin RA
    Psychopharmacology (Berl); 2004 Mar; 172(2):233-40. PubMed ID: 14598016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross generalization with LSD and yohimbine in the rat.
    Colpaert FC
    Eur J Pharmacol; 1984 Jul; 102(3-4):541-4. PubMed ID: 6489439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distortions of vision and pain: two functional facets of D-lysergic acid diethylamide.
    Williams JM
    Percept Mot Skills; 1979 Oct; 49(2):499-528. PubMed ID: 229462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The stimulus properties of LSD in C57BL/6 mice.
    Winter JC; Kieres AK; Zimmerman MD; Reissig CJ; Eckler JR; Ullrich T; Rice KC; Rabin RA; Richards JB
    Pharmacol Biochem Behav; 2005 Aug; 81(4):830-7. PubMed ID: 16005500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of clozapine with the stimulus effects of DOM and LSD.
    Palumbo PA; Winter JC
    Pharmacol Biochem Behav; 1994 Sep; 49(1):115-20. PubMed ID: 7816860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs and the discrimination of duration.
    Altman JL; Appel JB; McGowan WT
    Psychopharmacology (Berl); 1979 Jan; 60(2):183-8. PubMed ID: 106429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of lysergic acid diethylamide (LSD-25) on perception with stabilized images.
    Kohn B; Bryden MP
    Psychopharmacologia; 1965 Apr; 7(5):311-20. PubMed ID: 5837309
    [No Abstract]   [Full Text] [Related]  

  • 20. The discriminative stimulus properties of LSD: mechanisms of action.
    Kuhn DM; White FJ; Appel JB
    Neuropharmacology; 1978; 17(4-5):257-63. PubMed ID: 652138
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.